SHARE

Kenvue full-year sales fall in 2025 despite strong Q4 performance

The J&J spinoff saw 2.1% full-year sales decline for 2025, though Q4 grew 3.2% aided by Neutrogena and Aveeno. Supply chain gains helped margins rise, as the business progresses toward its Kimberly-Clark $48.7bn acquisition.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.